|
Delayed
NYSE
21:10:00 13/11/2025 GMT
|
5-day change | 1st Jan Change | ||
| 31.61 USD | -0.37% |
|
+3.30% | +6.90% |
Investment objective
Putnam BioRevolutionTM ETF Seeks long-term capital appreciation by investing mainly in common stocks of companies of any size with a focus on those that Putnam believes offer the opportunity to capitalize on a convergence of technological developments in the life sciences sector.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
| 602.60USD | -0.07% | +4.58% | 7.08% | ||
| 204.52USD | -0.34% | -10.36% | 6.67% | ||
| 375.36USD | -1.25% | +24.35% | 5.42% | ||
| 224.29USD | -0.64% | +20.27% | 5.2% | ||
| 330.90USD | -2.20% | +5.96% | 4.97% | ||
| 85.64USD | -0.30% | +27.65% | 4.32% | ||
| 248.90USD | +0.05% | +9.02% | 4.16% | ||
| 806.07USD | -0.52% | +4.50% | 4.05% | ||
| 1,121.88USD | -0.18% | +4.71% | 3.56% | ||
- Stock Market
- ETF
- SYNB ETF
Select your edition
All financial news and data tailored to specific country editions

















